Loading…

Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C

Aliment Pharmacol Ther 2012; 35: 92–104 Summary Background  Preliminary data suggest that performance of non‐invasive markers for liver fibrosis in hepatitis C may improve when combined. Three algorithms based on the combination of Fibrotest, Forns’ index and AST‐to‐platelet ratio (APRI) have been p...

Full description

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2012-01, Vol.35 (1), p.92-104
Main Authors: Sebastiani, G., Halfon, P., Castera, L., Mangia, A., Di Marco, V., Pirisi, M., Voiculescu, M., Bourliere, M., Alberti, A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aliment Pharmacol Ther 2012; 35: 92–104 Summary Background  Preliminary data suggest that performance of non‐invasive markers for liver fibrosis in hepatitis C may improve when combined. Three algorithms based on the combination of Fibrotest, Forns’ index and AST‐to‐platelet ratio (APRI) have been proposed: Sequential Algorithm for Fibrosis Evaluation (SAFE biopsy); Fibropaca algorithm; Leroy algorithm. Aim  To compare three algorithms to diagnose significant fibrosis (≥F2 by METAVIR) and cirrhosis (F4). Methods  A total of 1013 HCV monoinfected cases undergoing liver biopsy were consecutively enrolled in seven centres. Fibrotest, APRI and Forns’ index were measured at the time of liver biopsy, considered the reference standard. Results  Overall, performance of combination algorithms was significantly higher than the single non‐invasive methods (P 
ISSN:0269-2813
1365-2036
DOI:10.1111/j.1365-2036.2011.04897.x